Novartis falls premarket after weaker Q1 results

Novartis AG

28/04/2026 07:42

** Shares in Novartis NOVN.S fall 3% in premarket trade after the Swiss drugmaker reported weaker-than-expected Q1 results

** Core operating income fell 12% to $4.9 billion, vs $5.1 billion expected by Visible Alpha consensus

** Core EPS dropped 15% to $1.99, compared with $2.28 in the same quarter last year

** While FY guidance was maintained, Vontobel says Q1 results were mixed, with sales below expectations and profitability falling more than expected

** Sales in the quarter slid to $13.1 billion from $13.2 billion last year

** JP Morgan expects investors to be disappointed by the 5% Core EPS miss

 (Reporting by Amir Orusov)

 ((Amir.orusov@thomsonreuters.com))